CS
ENSC icon

Clear Street’s Ensysce Biosciences ENSC Stock Holding History

Clear Street’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+1
New – ﹤0.01% 1417

Other funds holding ENSC

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TIAM2
Tru Independence Asset Management 2 Portland, Oregon $185M AUM 20.3% 1-Year Est. Return

Clear Street's ENSC Position: Q2 2026 in Review

Clear Street opened a new position in Ensysce Biosciences (ENSC) in Q2 2026: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1417 among its holdings.

18 funds tracked by Wall St. Rank hold ENSC as of Q2 2026.

  • Clear Street held 1 share of Ensysce Biosciences worth $0 as of Q2 2026.
  • Ensysce Biosciences was a new Clear Street position in Q2 2026.
  • Ensysce Biosciences made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1417 holding.
  • 18 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.